Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : How To Write Covered Calls - An Ongoing Real Case Study! -- Ignore unavailable to you. Want to Upgrade?

To: Herm who wrote (6209)	12/26/1997 9:56:00 AM
From: Herm	Read Replies (1) \| Respond to of 14162

Hi everybody! In reading my IBD, I came accross the short interest results from Nov. 14 to Dec. 15, 1997. VVUS + 2% to 10,211,586 shares shorted or 5.75 days short squeeze! TECD - 55% to 520,535 shares shorted or < 1 day of short squeeze! SCOP - 20% to 1,102,196 shares shorted or 3.71 days of short squeeze! UGLY - 2% to 3,108,835 shares shorted or 9.22 days of short squeeze! UGLY and VVUS have a potential for some explosive price reversals when some earnings or news is released. In the case of VVUS, the successful new plant opening without a hitch and better earnings figures than recently projected could ignite the stock and bring it back to the $18 level fast! An $8 increase on a $10.50 stock price is a 84% ROI! Heck, another Vinik short squeeze play at this point would be easy and could bring in other institutional buyers overnight! CCers would be wise to stay on the sidelines and wait for the VVUS price climb before locking in those at the money CC premies and wait for the profit taking to start. NASDAQ: (VVUS : $10 5/8) $298 million Market Cap at December 26, 1997 Trades at a 63% Discount PE Multiple of 10.2 X, vs. the 27.3 X average multiple at which the Biomedics SubIndustry is priced.